Cargando…

Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India

INTRODUCTION: Following the withdrawal of Sabin type 2 from trivalent oral poliovirus vaccine (tOPV) in 2016, the introduction of ≥1 dose of inactivated poliovirus vaccine (IPV) in routine immunization was recommended, either as 1 full dose (0.5mL, intramuscular) or 2 fractional doses of IPV (fIPV—0...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmad, Mohammad, Verma, Harish, Deshpande, Jagadish, Kunwar, Abhishek, Bavdekar, Ashish, Mahantashetti, Niranjana S, Krishnamurthy, Balasundaram, Jain, Manish, Mathew, Mannancheril A, Pawar, Shailesh D, Sharma, Deepa K, Sethi, Raman, Visalakshi, Jayaseelan, Mohanty, Lalitendu, Bahl, Sunil, Haldar, Pradeep, Sutter, Roland W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865014/ https://www.ncbi.nlm.nih.gov/pubmed/34791350 http://dx.doi.org/10.1093/jpids/piab091

Ejemplares similares

Poliomyelitis seroprevalence in high risk populations of India before the trivalent-bivalent oral poliovirus vaccine switch in 2016
por: Ahmad, Mohammad, et al.
Publicado: (2021)

Vaccine-Derived Polioviruses Not Detected by Global Surveillance Screening Assay
por: Sharma, Deepa K., et al.
Publicado: (2015)

Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus
por: Dey, Ayan, et al.
Publicado: (2016)

Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children
por: Tagbo, Beckie N, et al.
Publicado: (2020)

Real-time reverse transcription-polymerase chain reaction assays for identification of wild poliovirus 1 & 3
por: Sharma, Deepa K., et al.
Publicado: (2015)

Assay for identification of heterozygous single-nucleotide polymorphism (Ala67Thr) in human poliovirus receptor gene
por: Nandi, Shyam Sundar, et al.
Publicado: (2016)

Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India
por: Mohanty, Madhu Chhanda, et al.
Publicado: (2017)

Differential induction of Toll-like receptors & type 1 interferons by Sabin attenuated & wild type 1 polioviruses in human neuronal cells
por: Mohanty, Madhu C., et al.
Publicado: (2013)

Poliovirus surveillance in patients with primary immunodeficiencies, India
por: Mohanty, Madhu Chhanda, et al.
Publicado: (2023)

One Full or Two Fractional Doses of Inactivated Poliovirus Vaccine for Catch-up Vaccination in Older Infants: A Randomized Clinical Trial in Bangladesh( )
por: Aziz, Asma B, et al.
Publicado: (2022)

Validation of a redesigned pan-poliovirus assay and real-time PCR platforms for the global poliovirus laboratory network
por: Sun, Hong, et al.
Publicado: (2021)

Fractional-dose inactivated poliovirus vaccine, India
por: Haldar, Pradeep, et al.
Publicado: (2019)

Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, Mozambique
por: de Deus, Nilsa, et al.
Publicado: (2020)

Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria
por: Iliyasu, Zubairu, et al.
Publicado: (2016)

Estimation of child vaccination coverage at state and national levels in India
por: Bhatnagar, Pankaj, et al.
Publicado: (2016)

Community-based survey to assess seroprevalence of poliovirus antibodies in far-north Cameroon in 2020
por: Claire Endegue, Marie, et al.
Publicado: (2022)

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies
por: Resik, Sonia, et al.
Publicado: (2015)

A Survey to Assess Serological Prevalence of Poliovirus Antibodies in Areas With High-Risk for Vaccine-Derived Poliovirus Transmission in Chad
por: Gamougam, Kadidja, et al.
Publicado: (2021)

Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in Madagascar
por: Razafindratsimandresy, Richter, et al.
Publicado: (2018)

Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia
por: Bashorun, Adedapo O, et al.
Publicado: (2021)

Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
por: Resik, Sonia, et al.
Publicado: (2018)

Estimating the Extent of Vaccine-Derived Poliovirus Infection
por: Wringe, Alison, et al.
Publicado: (2008)

Achieving high seroprevalence against polioviruses in Sri Lanka-Results from a serological survey, 2014
por: Gamage, Deepa, et al.
Publicado: (2015)

Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria
por: Verma, Harish, et al.
Publicado: (2018)

Inactivated Poliovirus Vaccine Closing the Type 2 Immunity Gap in Vietnam
por: Huyen, Dang Thi Thanh, et al.
Publicado: (2022)

Bioequivalence of two tacrolimus 1-mg formulations under fasting conditions in healthy subjects: A randomized, two-period crossover trial
por: Mohanty, Lalitendu, et al.
Publicado: (2020)

Recent poliovirus outbreaks and vaccination: A perspective
por: Sethi, Yashendra, et al.
Publicado: (2022)

Survey of poliovirus antibodies in Borno and Yobe States, North-Eastern Nigeria
por: Gofama, Mustapha Modu, et al.
Publicado: (2017)

Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014–2017
por: Grassly, Nicholas C., et al.
Publicado: (2018)

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants
por: Lalwani, Sanjay K., et al.
Publicado: (2016)

Safety, immunogenicity and non-interference of concomitant Typhoid Vi capsular polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV®) and measles or measles-mumps-rubella vaccines in 8–9 months-old Indian children
por: Vadrevu, Krishna Mohan, et al.
Publicado: (2022)

Progress Toward Containment of Poliovirus Type 2 — Worldwide, 2017
por: Previsani, Nicoletta, et al.
Publicado: (2017)

Progress Toward Poliovirus Containment Implementation — Worldwide, 2017–2018
por: Fournier-Caruana, Jacqueline, et al.
Publicado: (2018)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2014–March 2015
por: Diop, Ousmane M., et al.
Publicado: (2015)

Facility-Associated Release of Polioviruses into Communities—Risks for the Posteradication Era
por: Bandyopadhyay, Ananda S., et al.
Publicado: (2019)

Direct detection of polioviruses using a recombinant poliovirus receptor
por: Gerloff, Nancy, et al.
Publicado: (2021)

The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region
por: Bahl, Sunil, et al.
Publicado: (2017)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2016–June 2017
por: Jorba, Jaume, et al.
Publicado: (2017)

The effect of maternal poliovirus antibodies on the immune responses of infants to poliovirus vaccines
por: Jia, Siyue, et al.
Publicado: (2020)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2017–June 2018
por: Jorba, Jaume, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3iarcnv9cgfbc7bservqae02l4